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Iron is an essentials element, which takes part in many vital processes. 
However, excessive iron can be toxic for the organism by catalyzing production of 
free radicals. Long-term administration of blood transfusions in the therapy of various 
anaemias is the most common cause of iron overload. Each transfuzion represents 
an intake of 200-250 mg iron in the organism, which due to low daily elimination (only 
1-2 mg) leads to iron overload. As a result, complications like cardiovascular 
impairment or liver fibrosis can emerge. The risk of these severe complications can 
be reduced by administration of iron chelators. 
Deferoxamine has been traditionally used for the chelation therapy of chronic 
iron overload, but to his disadvantages belong frequent parenteral applications. In 
these days we can also use modern orally acive chelators (deferipron, deferoxamin). 
Furthermore, there is a wide range of potentially new indications (inflammation, 
tumor, cardiovascular and neurodegenerative diseases). In all these conditions 
oxidative stress plays an important role. It is necessary to remind that the efficiency 
of chelation therapy can differ in dependence on pH, and pH reduction is well 
documented in some of pathological conditions mentioned above. 
The aim of this study was the comparison of chelation efficiency of registred 
orally active chelators (deferipron, deferasirox) and a group of 8-hydroxyquinolines 
(8-OH-Q, chloroxin, cliochinol) inpathophysiologically important pHs. Chelation 
efficiency was measured by spectrofotometric method using ferrozine. Statistical 
analyzis was performed by comparison of 95% confidence intervals. 
It was found out, that the activity of tested chelators rised with increasing pH. 
Although some of the chelators – cliochinol, cloroxin, deferipron - chelated ferrous 
ions with equal efficiency at pH 5.5-7.5, their chelation potencial was lower at pH 4.5. 
The most efficient ferrous chelator at pH 7.5 was deferasirox. At pH 4.5 all chelators 
were relatively less efficient. Chelation curves at pH 7.5 for ferrous ions were almost 
identical to chelation curves for chelation of total iron at pH 4.5, which suggests high 
afinity of chelators to ferric ions. 
All chelators formed stable complexes with iron and ferric ions were not 
reduced to redox-active ferrous ions. 
In conlusion, at neutral pH there are probably not big differences among tested 
efficient chelators, but in conditions connectected  with acidosis it is worth having 
a respect to different chelation activity of these substances. 
 
